361 related articles for article (PubMed ID: 22640851)
1. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
2. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
3. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
4. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhaled dry powder mannitol on mucus and its clearance.
Daviskas E; Rubin BK
Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Daviskas E; Anderson SD; Eberl S; Young IH
Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
[TBL] [Abstract][Full Text] [Related]
7. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G
Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929
[TBL] [Abstract][Full Text] [Related]
8. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
Daviskas E; Robinson M; Anderson SD; Bye PT
J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Boogaard R; de Jongste JC; Merkus PJ
Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
[TBL] [Abstract][Full Text] [Related]
10. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2006 Apr; (2):CD002996. PubMed ID: 16625566
[TBL] [Abstract][Full Text] [Related]
11. Inhaled mannitol in cystic fibrosis.
Wills PJ
Expert Opin Investig Drugs; 2007 Jul; 16(7):1121-6. PubMed ID: 17594195
[TBL] [Abstract][Full Text] [Related]
12. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
Gjoerup J; Hilberg O; Bendstrup E
Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
[TBL] [Abstract][Full Text] [Related]
13. The use of pulmonary clearance medications in the acutely ill patient.
Papacostas MF; Luckett P; Hupp S
Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
[TBL] [Abstract][Full Text] [Related]
14. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
15. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
Daviskas E; Anderson SD; Young IH
Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
[TBL] [Abstract][Full Text] [Related]
16. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
Kellett F; Robert NM
Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
[TBL] [Abstract][Full Text] [Related]
17. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Main E; Grillo L; Rand S
Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
[TBL] [Abstract][Full Text] [Related]
18. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.
Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A
Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770
[TBL] [Abstract][Full Text] [Related]
19. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
Máiz Carro L; Martínez-García MA
Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
[TBL] [Abstract][Full Text] [Related]
20. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2001; (2):CD002996. PubMed ID: 11406058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]